参考文献:1.Antachopoulos C, Karvanen G, Leone M, Broggi G (2010) Serum and cerebrospinal fluid levels of colistin in pediatric patients. Antimicrob Agent Chemother 54:3985-7CrossRef 2.Cascio A, Conti A, Sinardi L, Iaria C, Angileri FF, Stassi G, David T, Versaci A, Iaria M, David A (2010) Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis 14:e572–e579CrossRef PubMed 3.Karaiskos I, Galani L, Baziaka F, Giamarellou H (2013) Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistance Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agent 41:499-08CrossRef 4.Markantonis SL, Markou N, Fousteri M, Sakellaridis N, Karatzas S, Alamanos I, Dimopoulou E, Baltopoulos G (2009) Penetration of colistin into cerebrospinal fluid. Antimicrob Agent Chemother 53:4907-0CrossRef 5.Michalopoulos A, Falagas M (2011) Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensiv Care 1:30CrossRef 6.Tunkel A, Hartman B, Kaplan S, Kaufman B, Roos K, Scheld M, Whitley R (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267-4CrossRef PubMed
作者单位:Ana Sofia Santos (1) (3) Amets Iraneta (2) Mário Matos (2) Maria Joao Brito (1)
1. Pediatric Infectious Diseases Unit, Hospital Dona Estefania, CHLC, Lisbon, Portugal 3. Servi?o Doen?as Infecciosas- CHSJ, Alameda Professor Hernani Monteiro, 4200-319, Porto, Portugal 2. Pediatric Neurosurgery Unit, Hospital Dona Estefania, CHLC, Lisbon, Portugal